​

Adverum Bio Ownership | Who Owns Adverum Bio?

OverviewForecastRevenueFinancialsChart

Adverum Bio Ownership Summary

Adverum Bio is owned by 64.26% institutional investors, 13.04% insiders, and 22.69% retail investors. Bml capital management is the largest institutional shareholder, holding 14.55% of ADVM shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 5.45% of its assets in Adverum Bio shares.

ADVM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAdverum Bio64.26%13.04%22.69%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bml capital management3.06M14.55%$6.57M
Tcg crossover management1.80M8.55%$3.86M
Frazier life sciences management1.07M5.09%$2.30M
Versant venture management506.82K2.43%$2.37M
Blackrock funding, inc. /de414.49K1.97%$891.14K
Pale fire capital se358.72K1.71%$771.26K
Soleus capital management287.25K1.37%$617.58K
Regeneron pharmaceuticals180.91K0.86%$388.95K
Waverly advisors160.58K0.76%$345.24K
Readystate asset management lp67.60K0.32%$145.34K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management3.06M4.97%$6.57M
Versant venture management506.82K2.73%$2.37M
Tcg crossover management1.80M0.44%$3.86M
Frazier life sciences management1.07M0.09%$2.30M
Pale fire capital se358.72K0.08%$771.26K
Soleus capital management287.25K0.04%$617.58K
Regeneron pharmaceuticals180.91K0.03%$388.95K
Quinn opportunity partners41.42K0.01%$89.05K
Point72 asia (singapore) pte.14.58K0.01%$31.35K
Readystate asset management lp67.60K0.00%$145.34K

Top Buyers

HolderShares% AssetsChange
Bml capital management3.06M4.97%315.21K
Readystate asset management lp67.60K0.00%67.60K
Marshall wace, llp49.63K0.00%49.63K
Qube research30.68K0.00%30.68K
Hrt financial lp30.63K0.00%30.63K

Top Sellers

HolderShares% AssetsChange
Franklin resources---1.76M
Blackrock funding, inc. /de414.49K--1.01M
Invesco---49.83K
Bank of new york mellon---49.32K
Charles schwab investment management---49.02K

New Positions

HolderShares% AssetsChangeValue
Readystate asset management lp67.60K0.00%67.60K$145.34K
Qube research30.68K0.00%30.68K$65.96K
Hrt financial lp30.63K0.00%30.63K$65.00K
Xtx topco29.75K0.00%29.75K$63.97K
Y-intercept (hong kong)21.12K0.00%21.12K$45.41K

Sold Out

HolderChange
Frazier financial advisors-1.00
Eversource wealth advisors-7.00
Gamma investing-47.00
Rothschild investment-100.00
Group one trading-292.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202557-18.57%13,501,908-11.69%641.21%27-6.90%19-17.39%
Mar 31, 2025712.90%15,830,377-0.28%751.31%29-19.44%23109.09%
Dec 31, 20241-506,821-241.19%----
Sep 30, 20241-50.00%506,821-79.85%21.04%----100.00%
Jun 30, 20242-33.33%2,515,161-29.83%151.22%--100.00%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Franklin Biotechnology Discv A(acc)USD1.14M5.45%-
Franklin Biotechnology Discovery A624.74K3.00%-
Vanguard US Total Market Shares ETF586.25K2.82%-
Vanguard Total Stock Mkt Idx Inv573.71K2.73%-12.54K
Fidelity Small Cap Index215.28K1.03%-757.00
Vanguard Institutional Extnd Mkt Idx Tr196.33K0.94%-89.46K
iShares Russell 2000 Value ETF181.86K0.87%-
CREF Stock R1140.59K0.68%-93.24K
Vanguard Russell 2000 ETF103.78K0.50%954.00
State St Russell Sm/Mid Cp® Indx NL Cl C94.53K0.45%-

Recent Insider Transactions

DateNameRoleActivityValue
May 15, 2025Soparkar Peter CHIEF OPERATING OFFICERSell$5.92K
May 15, 2025Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICERSell$1.85K
May 15, 2025Fischer Laurent CEO, PRESIDENT AND DIRECTORSell$18.25K
Mar 27, 2025Leonard Braden Michael-Buy$86.09K
Apr 22, 2025Leonard Braden Michael-Buy$900.00K

Insider Transactions Trends

DateBuySell
2025 Q233
2025 Q110-
2024 Q33-
2024 Q2--
2024 Q12-

ADVM Ownership FAQ

Who Owns Adverum Bio?

Adverum Bio shareholders are primarily institutional investors at 64.26%, followed by 13.04% insiders and 22.70% retail investors. The average institutional ownership in Adverum Bio's industry, Biotech Stocks , is 306.59%, which Adverum Bio falls below.

Who owns the most shares of Adverum Bio?

Adverum Bio’s largest shareholders are Bml capital management (3.06M shares, 14.55%), Tcg crossover management (1.8M shares, 8.55%), and Frazier life sciences management (1.07M shares, 5.09%). Together, they hold 28.19% of Adverum Bio’s total shares outstanding.

Does Blackrock own Adverum Bio?

BlackRock is not among the top 10 institutional shareholders of Adverum Bio.

Who is Adverum Bio’s biggest shareholder by percentage of total assets invested?

Bml capital management is Adverum Bio’s biggest shareholder by percentage of total assets invested, with 4.97% of its assets in 3.06M Adverum Bio shares, valued at 6.57M$.

Who is the top mutual fund holder of Adverum Bio shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Adverum Bio shares, with 5.45% of its total shares outstanding invested in 1.14M Adverum Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools